See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2023_CUMBERLAND_PHARMACEUTICALS_INC.pdf
Logs
Graph
Absolute values for 0001087294, CUMBERLAND PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,870,210 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 31,504,678 |
| 2 | PropertyPlantAndEquipmentNet | 284,039 |
| 3 | remainder_Assets | 15,266,231 |
| 4 | LiabilitiesCurrent | 28,579,832 |
| 5 | LiabilitiesNoncurrent | 12,171,320 |
| 6 | remainder_Liabilities | 16,200,000 |
| 7 | CostOfGoodsAndServicesSold | 9,118,521 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,180,120 |
| 9 | ResearchAndDevelopmentExpense | 6,688,924 |
| 10 | remainder_Expenses | 22,383,158 |
| 11 | remainder_Revenues | 42,010,949 |
| 12 | remainder_NetIncome | 709,735 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 92,925,158 |
| 1 | Liabilities | 56,951,152 |
| 2 | Expenses | 48,370,723 |
| 3 | Revenues | 42,010,949 |
| 4 | StockholdersEquity | 35,974,006 |
| 5 | NetIncome | -5,650,039 |
| 6 | ComprehensiveNetIncome | -5,650,039 |
| 7 | BaseVar | 120,483,858 |
| 8 | EconomicCapitalRatio | 0.750 |
Edgar->Model Mapping
Feature Distribution
Change over Time
